Edgardo Baracchini Jr. - 14 May 2024 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Reporting relationship: Director
Issuer ticker: INMB
Reported as of: 14 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 May 2024, 16:06:35 UTC
Prior SEC filing: 21 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Edgardo Baracchini Jr

Key filing fact

Edgardo Baracchini Jr. filed Form 4 for Inmune Bio, Inc. (INMB) on 16 May 2024.

Key facts

This page summarizes Edgardo Baracchini Jr.'s Form 4 filing for Inmune Bio, Inc. (INMB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 May 2024, 16:06.

Change

Previous filing in this sequence was filed on 21 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INMB transaction Derivative

Option (right to buy)

Award

Transaction value: $0
Shares: +12,500
Change %
Price: $0.000000
Shares after: 12,500
Date: 14 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price: $9.92
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Granted pursuant to the 2021 Stock Incentive Plan. The Option will become vested and exercisable 1/12th every month until the Option is 100% vested which shall occur on the one-year anniversary of the grant date.